Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃

Introduction/Overview

Berberine Sulfate (CAS No.: 633-66-9) is a natural alkaloid isolated from the traditional Chinese medicine Coptis chinensis, belonging to the isoquinoline alkaloid family. As a long-established Chinese herbal ingredient, berberine has attracted attention for its diverse pharmacological activities, especially showing significant potential in antibacterial, anti-inflammatory, anti-tumor, and metabolic regulation fields. Berberine in sulfate form not only maintains the biological effects of its active ingredients but also enhances its clinical feasibility by improving water solubility and bioavailability.

In recent years, with the rapid development of molecular pharmacology and natural product chemistry, the mechanism of action of berberine sulfate has gradually been revealed, especially in research on inducing reactive oxygen species (ROS) generation, inhibiting DNA topoisomerase, and regulating various cellular signaling pathways, achieving breakthrough progress. In addition, berberine sulfate has attracted widespread attention for its potential therapeutic value in neurological diseases such as migraine disorders, with related targets involving key molecules including ALOX15, BCHE, ACHE, EDNRA, DRD1, ADRA1A, TAAR1, EP300, and P2RX7.

This paper aims to systematically review the chemical structure and physicochemical properties of berberine sulfate, plant origin and extraction methods, pharmacological activity and mechanism of action, druggability evaluation, and pharmacokinetic characteristics, and to explore its prospects and challenges in clinical application, providing scientific basis and theoretical support for subsequent research and development.

Chemical structure and physicochemical properties

Berberine sulfate has the chemical formula C20H18NO4S and a molecular weight of 431.42. Its structural core is an isoquinoline skeleton, containing multiple oxygen-containing functional groups and a sulfate anion. The molecular structure contains nine hydrogen bond receptors, which greatly affect its ability to bind to biological macromolecules. The LogP value of -0.66 indicates strong hydrophilicity, which is closely related to the enhanced water solubility in its sulfate form. TPSA (topological pole surface area) is 119.89 Ų, indicating high polarity, and these compounds typically have weaker membrane penetration ability.

The physicochemical properties of berberine sulfate determine its distribution and metabolic characteristics in the body. Its ability to penetrate the blood-brain barrier is relatively low, suggesting that its direct role in the central nervous system may be limited. However, by modulating targets in the peripheral nerve and vascular system, it can still exert neuroprotective and anti-inflammatory effects. Additionally, berberine sulfate exhibits cardiotoxicity and hERG channel inhibitory activity, suggesting that its potential cardiovascular safety should be considered in clinical practice.

Plant Origins and Extraction Methods

Berberine sulfate mainly comes from traditional Chinese medicinal herbs such as Coptis chinensis Franch., Phellodendron (Phellodendron amurense Rupr.), and other plants containing berberine. Coptis chinensis, as an important herb in traditional Chinese medicine for clearing heat, drying dampness, detoxifying, and stopping diarrhea, is rich in berberine alkaloids in its rhizomes.

Traditional extraction methods usually use water or alcohol solvents for extraction and then separation and purification through acidic precipitation, alkaline reflux, column chromatography, and other processes. Modern extraction technologies such as ultrasound-assisted extraction, microwave-assisted extraction, and high-performance liquid chromatography (HPLC) purification methods have improved extraction efficiency and purity. Sulfate forms are typically prepared by reacting berberine with sulfuric acid to form salts, enhancing their water solubility and stability, which facilitates drug formulation development.

Pharmacological activity research

Antibacterial effects

Berberine sulfate, as a traditional natural antibiotic product, has been widely reported to inhibit various bacteria, fungi, and parasites. Its mechanisms mainly involve cell membrane destruction, inhibition of nucleic acid synthesis, and disruption of energy metabolism. Research shows that berberine sulfate is significantly active against both Gram-positive and Gram-negative bacteria, and exhibits a certain inhibitory effect on resistant strains.

Antitumor activity

Berberine sulfate induces intracellular reactive oxygen species (ROS) production, triggering apoptosis and autophagy, demonstrating broad antitumor effects. It can inhibit DNA topoisomerase activity, block DNA replication and repair in tumor cells, leading to cell cycle stagnation and death. Additionally, berberine sulfate regulates multiple signaling pathways (such as PI3K/Akt, MAPK, NF-κB, etc.), inhibiting tumor cell proliferation, migration, and invasion.

Neuroprotective and anti-inflammatory effects

Although berberine sulfate has limited blood-brain barrier penetration, it has a significant regulatory effect on the peripheral nervous system and vascular system. By inhibiting acetylcholinesterase (ACHE) and butyrylcholinesterase (BCHE), neurotransmitter metabolism is regulated and neurological dysfunction is improved. Meanwhile, berberine sulfate reduces inflammatory responses and oxidative stress by regulating targets such as ALOX15, EDNRA, and DRD1, demonstrating potential therapeutic value for migraines and other neurological diseases.

Metabolic regulation

Berberine sulfate also plays a positive role in regulating glycolipid metabolism, improving insulin resistance, lowering blood sugar and lipid levels, and possessing potential anti-diabetes and cardiovascular protective effects.

Mechanism of action and molecular targets

The pharmacological effects of berberine sulfate involve multi-target and multi-pathway coordinated regulation, mainly including:

• Reactive oxygen species (ROS) generation: Excessive ROS production is induced by interference with mitochondrial function, triggering apoptosis signals.
• DNA topoisomerase inhibition: inhibits DNA replication and repair, leading to tumor cell death.
• Neurotransmitter enzyme regulation: Inhibits ACE and BCHE, prolongs the duration of acetylcholine action, and improves nerve conduction.
• Vasoconstrictor regulation: acts on endothelin receptor A (EDNRA) and α1 adrenergic receptor (ADRA1A), modulating vascular tone and relieving migraine-related vasospasms.
• Dopamine receptor D1 (DRD1) and TAAR1 receptor regulation: involved in neural signal transmission and emotional regulation.
• Histone acetyltransferase EP300 regulation: affects gene expression and cell proliferation.
• P2X7 receptor (P2RX7) regulation: mediates inflammatory responses and apoptosis.

The combined regulation of these targets enables berberine sulfate to exhibit significant pharmacological activity in anti-tumor, neuroprotective, and anti-inflammatory aspects.

Druggability evaluation and pharmacokinetics

Berberine sulfate had a molecular weight of 431.42 and a LogP of -0.66, indicating strong hydrophilicity and high TPSA, indicating limited cell membrane permeability. The blood-brain barrier has a low penetration capacity, limiting the direct action of the central nervous system. The metabolic pathway in vivo is not yet fully understood, but its hepatotoxicity is known to be uncertain and requires further systematic evaluation. Its cardiotoxicity and hERG channel inhibitory activity suggest a potential risk of arrhythmias, and clinical use requires cautious monitoring of cardiovascular safety.

The preparation of sulfate forms significantly improves its water solubility and bioavailability, enhancing oral absorption and efficacy. Pharmacokinetic studies show that berberine sulfate is widely distributed in the body but metabolizes rapidly and has a short half-life, suggesting the need to optimize the administration regimen to maintain effective plasma concentrations.

Prospects and outlooks for clinical applications

Berberine sulfate, as a natural product with multiple targets and multiple mechanisms, has broad clinical application potential. Its application prospects in anti-infective, anti-tumor, neuroprotection, and metabolic disease treatment are highly anticipated. Especially in the treatment of migraine disorders, by regulating multiple targets such as ALOX15, ACHE, and EDNRA, berberine sulfate can effectively relieve vascular spasms and neuroinflammation, offering new therapeutic approaches.

However, the cardiotoxicity of berberine sulfate and the risk of hERG channel inhibition are major obstacles to its clinical development, requiring structural modification, formulation optimization, and combination therapy strategies to reduce toxic side effects. At the same time, in-depth pharmacokinetic and toxicological studies are key to driving its clinical translation.

Future research should focus on:

• Optimize molecular structure to enhance the blood-brain barrier penetration and targeting;
• Combined with modern drug delivery systems, it enhances bioavailability and tissue specificity;
• Systematic evaluation of safety, especially mechanisms of cardiovascular toxicity and hepatotoxicity;
• Clinical multicenter, large-sample randomized controlled trials to verify efficacy and safety.

Conclusion

Berberine sulfate, as a natural product with rich pharmacological activity, demonstrates unique advantages in anti-tumor, neuroprotection, and anti-infective fields due to its multi-target regulation and multiple biological effects. The development of its sulfate form has effectively improved water solubility and bioavailability, providing a solid foundation for clinical application. Despite safety challenges such as cardiotoxicity, through scientific drug design and sound clinical strategies, berberine sulfate is expected to become an important candidate for future natural drug development.

Based on current research progress, in-depth exploration of berberine sulfate mechanisms and clinical translation studies will inject new vitality into the field of natural product pharmacology and promote its widespread application in modern medicine.